| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |